US 10,758,239 · Application 15/358,483 · Granted Sep 1, 2020
US 10,758,239
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
Estimated expiration
January 23, 2023
Expired 1343 days ago
Earliest effective filing
Sep 10, 2002
+ 20 years
Sep 10, 2022
PTA +830d
Dec 18, 2024
TD cap (US 9,533,116)
Jan 23, 2023
Final
Jan 23, 2023
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- November 22, 2016
- Earliest effective filing
- September 10, 2002
- Issue date
- September 1, 2020
- PTA
- +830 days
- Base expiry (before PTA)
- September 10, 2022
September 10, 2002 + 20 years = September 10, 2022 + 830 PTA days = December 18, 2024
- Continuation of application 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
- Continuation of application 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
- Continuation-in-part of application 11/685,008, filed Mar 12, 2007
- Continuation-in-part of application 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
- Continuation-in-part of application 10/241,733, filed Sep 10, 2002
- Continuation-in-part of application 11/685,008, filed Mar 12, 2007
- Continuation-in-part of application 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
- Continuation of application 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
- Continuation-in-part of application 11/685,008, filed Mar 12, 2007
- Continuation-in-part of application 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
- PRO60/699,289 — Provisional — not used for base term
- PRO60/696,940 — Provisional — not used for base term
- PRO60/645,711 — Provisional — not used for base term
- PRO60/318,539 — Provisional — not used for base term
- PRO60/318,539 — Provisional — not used for base term
- PRO60/699,289 — Provisional — not used for base term
- PRO60/696,940 — Provisional — not used for base term
- PRO60/645,711 — Provisional — not used for base term
- PRO60/645,711 — Provisional — not used for base term
- PRO60/696,940 — Provisional — not used for base term
- PRO60/699,289 — Provisional — not used for base term
- PRO60/645,711 — Provisional — not used for base term
- PRO60/696,940 — Provisional — not used for base term
- PRO60/699,289 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to January 23, 2023 (earliest expiring referenced patent: US 9,533,116)
US 9,533,116· Application 13/938,025Capping patent
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
- Filing date
- Jul 9, 2013
- Earliest effective filing
- Sep 10, 2002
- Issue date
- Jan 3, 2017
- PTA
- +135 days
- Calculated expiration
- Jan 23, 2023
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation-in-part of 10/241,733, filed Sep 10, 2002
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Sep 10, 2002 + 20y + 135d PTA = Jan 23, 2023
US 8,496,006· Application 12/820,547
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
- Filing date
- Jun 22, 2010
- Earliest effective filing
- Sep 10, 2002
- Issue date
- Jul 30, 2013
- PTA
- +356 days
- Calculated expiration
- Sep 1, 2023
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation-in-part of 10/241,733, filed Sep 10, 2002
Sep 10, 2002 + 20y + 356d PTA = Sep 1, 2023
US 10,758,239· Application 15/358,483(from application 15/358,483)
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
- Filing date
- Nov 22, 2016
- Earliest effective filing
- Sep 10, 2002
- Issue date
- Sep 1, 2020
- PTA
- +830 days
- Calculated expiration
- Dec 18, 2024
Continuation of 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation-in-part of 10/241,733, filed Sep 10, 2002
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Sep 10, 2002 + 20y + 830d PTA = Dec 18, 2024
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 15/358,483 · US 10,758,239
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 10,758,239: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US10758239Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.